Global African Trypanosomiasis Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 15204

African Trypanosomiasis, also known as sleeping sickness disease, is one of the rarest infectious diseases that can affect one’s sleep pattern to a great extent. It is a parasitic disease caused by protozoan parasite of genus Trypanosoma and is carried by tsetse fly. There are two types of African Trypanosomiasis depending on the parasite: East African Trypanosomiasis caused by Trypanosoma brucei rhodesiense and West African Trypanosomiasis caused by Trypanosomiasis brucei gambiense. 
According to WHO, 25,000 new cases of both East and West African Trypanosomiasis are reported each year globally. African Trypanosomiasis is primarily found in subtropical and equatorial Africa. The major driving factors for the growth of the African Trypanosomiasis market in this region are constantly growing number of poor population in East African, prevalence of unhygienic environment, rapid pace of technological advancement in the field of African Trypanosomiasis therapeutics, increasing number of population to opt for healthy lifestyle and the overall growing diagnostic and therapeutic market. On the other hand, the huge cost of drugs involved in the treatment of African Trypanosomiasis and difficulty in availability of these medications would most likely impede the growth of this market.
The symptoms associated with African Trypanosoniasis vary from one stage to another. There are two stages which are as follows. First Stage (Hemolymphatic stage): The first stage is known as hemolymphatic stage due to the blood and lymphatic systems associated with this stage. During this stage, the skin infected by the tsetse fly form a trypanosomal chancre and the lymph nodes of the immune system become infected and enlarged. The various symptoms of the hemolymphatic stage are intermittent fever, headaches, skin lesions, facial edema, tachycardia and weight loss. Second stage (Neurologic or encephalitic stage): During the second stage, the brain becomes affected with few troubles in concentrating. The various symptoms of the neurologic stage are muscle weakness, behavioral changes such as irritability and mood swings, paralysis of a limb, speech disorders and sensory disorders.
In 2018, the global African Trypanosomiasis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global African Trypanosomiasis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the African Trypanosomiasis development in United States, Europe and China.

The key players covered in this study
Sanofi
Genzyme Corporation
aRigen Pharmaceuticals
Immtech Pharmaceuticals
Anacor Pharmaceuticals
...

Market segment by Type, the product can be split into
Trypanosoma Brucei Rhodesiense
Trypanosomiasis Brucei Gambiense

Market segment by Application, split into
Blood Samples
Bone Marrow
Lymph Node Fluid
Cerebrospinal Fluid or Lymph Node Aspirate

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global African Trypanosomiasis status, future forecast, growth opportunity, key market and key players.
To present the African Trypanosomiasis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of African Trypanosomiasis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global African Trypanosomiasis Market Size Growth Rate by Type (2014-2025)
1.4.2 Trypanosoma Brucei Rhodesiense
1.4.3 Trypanosomiasis Brucei Gambiense
1.5 Market by Application
1.5.1 Global African Trypanosomiasis Market Share by Application (2014-2025)
1.5.2 Blood Samples
1.5.3 Bone Marrow
1.5.4 Lymph Node Fluid
1.5.5 Cerebrospinal Fluid or Lymph Node Aspirate
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 African Trypanosomiasis Market Size
2.2 African Trypanosomiasis Growth Trends by Regions
2.2.1 African Trypanosomiasis Market Size by Regions (2014-2025)
2.2.2 African Trypanosomiasis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 African Trypanosomiasis Market Size by Manufacturers
3.1.1 Global African Trypanosomiasis Revenue by Manufacturers (2014-2019)
3.1.2 Global African Trypanosomiasis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global African Trypanosomiasis Market Concentration Ratio (CR5 and HHI)
3.2 African Trypanosomiasis Key Players Head office and Area Served
3.3 Key Players African Trypanosomiasis Product/Solution/Service
3.4 Date of Enter into African Trypanosomiasis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global African Trypanosomiasis Market Size by Type (2014-2019)
4.2 Global African Trypanosomiasis Market Size by Application (2014-2019)

5 United States
5.1 United States African Trypanosomiasis Market Size (2014-2019)
5.2 African Trypanosomiasis Key Players in United States
5.3 United States African Trypanosomiasis Market Size by Type
5.4 United States African Trypanosomiasis Market Size by Application

6 Europe
6.1 Europe African Trypanosomiasis Market Size (2014-2019)
6.2 African Trypanosomiasis Key Players in Europe
6.3 Europe African Trypanosomiasis Market Size by Type
6.4 Europe African Trypanosomiasis Market Size by Application

7 China
7.1 China African Trypanosomiasis Market Size (2014-2019)
7.2 African Trypanosomiasis Key Players in China
7.3 China African Trypanosomiasis Market Size by Type
7.4 China African Trypanosomiasis Market Size by Application

8 Japan
8.1 Japan African Trypanosomiasis Market Size (2014-2019)
8.2 African Trypanosomiasis Key Players in Japan
8.3 Japan African Trypanosomiasis Market Size by Type
8.4 Japan African Trypanosomiasis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia African Trypanosomiasis Market Size (2014-2019)
9.2 African Trypanosomiasis Key Players in Southeast Asia
9.3 Southeast Asia African Trypanosomiasis Market Size by Type
9.4 Southeast Asia African Trypanosomiasis Market Size by Application

10 India
10.1 India African Trypanosomiasis Market Size (2014-2019)
10.2 African Trypanosomiasis Key Players in India
10.3 India African Trypanosomiasis Market Size by Type
10.4 India African Trypanosomiasis Market Size by Application

11 Central & South America
11.1 Central & South America African Trypanosomiasis Market Size (2014-2019)
11.2 African Trypanosomiasis Key Players in Central & South America
11.3 Central & South America African Trypanosomiasis Market Size by Type
11.4 Central & South America African Trypanosomiasis Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 African Trypanosomiasis Introduction
12.1.4 Sanofi Revenue in African Trypanosomiasis Business (2014-2019)
12.1.5 Sanofi Recent Development
12.2 Genzyme Corporation
12.2.1 Genzyme Corporation Company Details
12.2.2 Company Description and Business Overview
12.2.3 African Trypanosomiasis Introduction
12.2.4 Genzyme Corporation Revenue in African Trypanosomiasis Business (2014-2019)
12.2.5 Genzyme Corporation Recent Development
12.3 aRigen Pharmaceuticals
12.3.1 aRigen Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 African Trypanosomiasis Introduction
12.3.4 aRigen Pharmaceuticals Revenue in African Trypanosomiasis Business (2014-2019)
12.3.5 aRigen Pharmaceuticals Recent Development
12.4 Immtech Pharmaceuticals
12.4.1 Immtech Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 African Trypanosomiasis Introduction
12.4.4 Immtech Pharmaceuticals Revenue in African Trypanosomiasis Business (2014-2019)
12.4.5 Immtech Pharmaceuticals Recent Development
12.5 Anacor Pharmaceuticals
12.5.1 Anacor Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 African Trypanosomiasis Introduction
12.5.4 Anacor Pharmaceuticals Revenue in African Trypanosomiasis Business (2014-2019)
12.5.5 Anacor Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details